A double-blinded randomized trial on growth and feeding tolerance with Saccharomyces boulardii CNCM I-745 in formula-fed preterm infants
Authors:
Open Access
- 1 May 2016
- journal article
- research article
- Published by Elsevier in Jornal de Pediatria
- Vol. 92 (3) , 296-301
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Factors influencing gastrointestinal tract and microbiota immune interaction in preterm infantsPediatric Research, 2015
- Practice of Enteral Nutrition in Very Low Birth Weight and Extremely Low Birth Weight Infants2014
- Probiotic supplement reduces risk of necrotizing enterocolitis and mortality in preterm very low-birth-weight infants: an updated meta-analysis of 20 randomized, controlled trialsJournal of Pediatric Surgery, 2012
- Evidence-based guidelines for use of probiotics in preterm neonatesBMC Medicine, 2011
- Enteral feeding for very low birth weight infants: reducing the risk of necrotising enterocolitisArchives of Disease in Childhood - Fetal and Neonatal Edition, 2007
- Probiotics for prevention of necrotising enterocolitis in preterm neonates with very low birthweight: a systematic review of randomised controlled trialsThe Lancet, 2007
- Clinical evaluation of a new starter formula for infants containing live Bifidobacterium longum BL999 and prebioticsNutrition, 2007
- Growth during the first 6 months of life in infants using formula enriched with Lactobacillus rhamnosus GG: double‐blind, randomized trialJournal of Human Nutrition and Dietetics, 2006
- Enteral feeding of premature infants with Saccharomyces boulardiiEarly Human Development, 2003
- Development of the Intestinal Bacterial Composition in Hospitalized Preterm Infants in Comparison with Breast-Fed, Full-Term InfantsPediatric Research, 2003